{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T09:48:55Z","timestamp":1783676935556,"version":"3.55.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001198","name":"Faculty of Science, Monash University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001198","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Ocular Surface"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.jtos.2019.10.008","type":"journal-article","created":{"date-parts":[[2019,10,24]],"date-time":"2019-10-24T20:05:23Z","timestamp":1571947523000},"page":"108-113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Dry eye signs and symptoms in aromatase inhibitor treatment and the relationship with pain"],"prefix":"10.1016","volume":"18","author":[{"given":"Emma","family":"Gibson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Stapleton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Dear","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James S.","family":"Wolffsohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blanka","family":"Golebiowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jtos.2019.10.008_bib1","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jtos.2017.05.003","article-title":"TFOS DEWS II epidemiology report","volume":"15","author":"Stapleton","year":"2017","journal-title":"Ocul Surf"},{"issue":"3","key":"10.1016\/j.jtos.2019.10.008_bib2","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jtos.2017.04.001","article-title":"TFOS DEWS II sex, gender, and hormones report","volume":"15","author":"Sullivan","year":"2017","journal-title":"Ocul Surf"},{"issue":"6","key":"10.1016\/j.jtos.2019.10.008_bib3","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1097\/00003226-200308000-00006","article-title":"Is complete androgen insensitivity syndrome associated with alterations in the meibomian gland and ocular surface?","volume":"22","author":"Cermak","year":"2003","journal-title":"Cornea"},{"issue":"12","key":"10.1016\/j.jtos.2019.10.008_bib4","first-page":"4874","article-title":"Effect of androgen deficiency on the human meibomian gland and ocular surface","volume":"85","author":"Krenzer","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.jtos.2019.10.008_bib5","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1136\/bjophthalmol-2013-304637","article-title":"Transdermal androgen patches in evaporative dry eye syndrome with androgen deficiency: a pilot study","volume":"98","author":"Nanavaty","year":"2014","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jtos.2019.10.008_bib6","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1136\/bjophthalmol-2017-310610","article-title":"Local synthesis of sex hormones: are there consequences for the ocular surface and dry eye?","volume":"101","author":"Gibson","year":"2017","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jtos.2019.10.008_bib7","first-page":"324","article-title":"Sex hormones and dry eye","volume":"97","author":"Truong","year":"2014","journal-title":"Clin Exp Ophthalmol"},{"key":"10.1016\/j.jtos.2019.10.008_bib8","doi-asserted-by":"crossref","first-page":"C113","DOI":"10.1016\/0303-7207(91)90116-A","volume":"78","author":"Labrie","year":"1991","journal-title":"Intracrinology. Molec Cell Endocrinol."},{"issue":"3","key":"10.1016\/j.jtos.2019.10.008_bib9","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1124\/pr.57.3.6","article-title":"Regulation of aromatase expression in estrogen-responsive breast and uterine disease: from bench to treatment","volume":"57","author":"Bulun","year":"2005","journal-title":"Pharmacol Rev"},{"issue":"July 2012","key":"10.1016\/j.jtos.2019.10.008_bib10","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1442-9071.2012.02865.x","article-title":"Dry eye syndrome in aromatase inhibitor users","volume":"41","author":"Turaka","year":"2013","journal-title":"Clin Exp Ophthalmol"},{"issue":"9922","key":"10.1016\/j.jtos.2019.10.008_bib11","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/S0140-6736(13)62292-8","article-title":"Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial","volume":"383","author":"Cuzick","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jtos.2019.10.008_bib12","first-page":"1","article-title":"Dry eyes and AIs: if you don't ask you won't find out","author":"Inglis","year":"2015","journal-title":"Breast"},{"key":"10.1016\/j.jtos.2019.10.008_bib13","first-page":"276","volume":"15","author":"Craig","year":"2017","journal-title":"TFOS DEWS II Definition and Classification Report"},{"key":"10.1016\/j.jtos.2019.10.008_bib14","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ajo.2015.11.017","article-title":"Clinical characteristics of dry eye patients with chronic pain syndromes","volume":"162","author":"Vehof","year":"2016","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jtos.2019.10.008_bib15","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1001\/jamaophthalmol.2013.4399","article-title":"Relationship between dry eye symptoms and pain sensitivity","volume":"131","author":"Vehof","year":"2013","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.jtos.2019.10.008_bib16","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1136\/bjophthalmol-2016-308473","article-title":"Does endogenous serum oestrogen play a role in Meibomian gland dysfunction in postmenopausal women with dry eye?","volume":"101","author":"Golebiowski","year":"2017","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jtos.2019.10.008_bib17","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1136\/bjophthalmol-2016-309498","article-title":"The effects of transdermal testosterone and oestrogen therapy on dry eye in post-menopausal women: a rondomised, placebo-controlled, pilot study","volume":"101","author":"Golebiowski","year":"2017","journal-title":"Br J Ophthalmol"},{"issue":"69","key":"10.1016\/j.jtos.2019.10.008_bib18","article-title":"The 2016 classification criteria for primary Sjogren's syndrome: what's new?","volume":"15","author":"Franceschini","year":"2017","journal-title":"BMC Med"},{"issue":"3","key":"10.1016\/j.jtos.2019.10.008_bib19","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jtos.2017.05.001","article-title":"TFOS DEWS II diagnostic methodology report","volume":"15","author":"Wolffsohn","year":"2017","journal-title":"Ocul Surf"},{"issue":"5","key":"10.1016\/j.jtos.2019.10.008_bib20","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1001\/archopht.118.5.615","article-title":"Reliability and validity of the ocular surface disease index","volume":"118","author":"Schiffman","year":"2000","journal-title":"Arch Ophthalmol"},{"issue":"1436","key":"10.1016\/j.jtos.2019.10.008_bib21","article-title":"Evaluating the functional impact of dry eye: the ocular surface disease index (OSDI)","volume":"31","author":"Walt","year":"1987","journal-title":"Drug Inf J"},{"issue":"0","key":"10.1016\/j.jtos.2019.10.008_bib22","first-page":"1","article-title":"Development of a meibomian gland dysfunction \u2013 specific symptom questionnaire","volume":"0","author":"Paugh","year":"2016","journal-title":"Eye Contact Lens"},{"issue":"5","key":"10.1016\/j.jtos.2019.10.008_bib23","first-page":"1","article-title":"Understanding ocular discomfort and dryness using the pain sensitivity questionnaire","volume":"11","author":"Li","year":"2016","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.jtos.2019.10.008_bib24","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1016\/j.ophtha.2016.03.006","article-title":"Validity and reliability of a novel ocular pain assessment Survey (OPAS) in quantifying and monitoring corneal and ocular surface pain","volume":"123","author":"Qazi","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jtos.2019.10.008_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtos.2019.06.005","article-title":"Daily fluctuations in ocular surface symptoms during the normal menstrual cycle and with the use of oral contraceptives","author":"Boga","year":"2019","journal-title":"Ocul Surf"},{"issue":"6","key":"10.1016\/j.jtos.2019.10.008_bib26","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.pain.2012.02.025","article-title":"Validation of the pain sensitivity questionnaire in chronic pain patients","volume":"153","author":"Ruscheweyh","year":"2012","journal-title":"Pain"},{"issue":"10","key":"10.1016\/j.jtos.2019.10.008_bib27","doi-asserted-by":"crossref","first-page":"3996","DOI":"10.1167\/iovs.15-18467","article-title":"Functional and morphologic changes of meibomian glands in an asymptomatic adult population","volume":"57","author":"Yeotikar","year":"2016","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"7","key":"10.1016\/j.jtos.2019.10.008_bib28","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1097\/00003226-200310000-00008","article-title":"Grading of corneal and conjunctival staining in the context of other dry eye tests","volume":"22","author":"Bron","year":"2003","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2019.10.008_bib29","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.ajo.2005.11.004","article-title":"Marx line: Fluorescein staining line on the inner lid as indicator of meibomian gland function","volume":"141","author":"Yamaguchi","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jtos.2019.10.008_bib30","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/eye.1991.65","article-title":"Meibomian gland disease. Classification and grading of lid changes","volume":"5","author":"Bron","year":"1991","journal-title":"Eye"},{"issue":"3","key":"10.1016\/j.jtos.2019.10.008_bib32","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S1542-0124(12)70139-8","article-title":"Meibomian gland dysfunction: a clinical scheme for description, diagnosis, classification, and grading","volume":"1","author":"Foulks","year":"2003","journal-title":"Ocul Surf"},{"issue":"10","key":"10.1016\/j.jtos.2019.10.008_bib33","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1097\/ICO.0b013e3181814cff","article-title":"Meibomian gland diagnostic expressibility: correlation with dry eye symptoms and gland location","volume":"27","author":"Korb","year":"2008","journal-title":"Cornea"},{"issue":"5","key":"10.1016\/j.jtos.2019.10.008_bib34","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s10384-010-0858-1","article-title":"Efficacy of diagnostic criteria for the differential diagnosis between obstructive meibomian gland dysfunction and aqueous deficiency dry eye","volume":"54","author":"Arita","year":"2010","journal-title":"Jpn J Ophthalmol"},{"issue":"11","key":"10.1016\/j.jtos.2019.10.008_bib35","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1016\/j.ophtha.2009.04.037","article-title":"Proposed diagnostic criteria for obstructive meibomian gland dysfunction","volume":"116","author":"Arita","year":"2009","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.jtos.2019.10.008_bib36","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1001\/archophthalmol.2009.356","article-title":"Minimal clinically important difference for the ocular surface disease index","volume":"128","author":"Miller","year":"2010","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jtos.2019.10.008_bib37","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1167\/iovs.15-18158","article-title":"Association between serum levels of testosterone and estradiol with meibomian gland assessments in postmenopausal women","volume":"57","author":"Ablamowicz","year":"2016","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"03","key":"10.1016\/j.jtos.2019.10.008_bib38","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0093-7754(03)00305-1","article-title":"Pharmacokinetics of third-generation aromatase inhibitors","volume":"30","author":"L\u00f8nning","year":"2003","journal-title":"Semin Oncol"},{"issue":"2","key":"10.1016\/j.jtos.2019.10.008_bib39","first-page":"120","article-title":"Ocular surface and tear film abnormalities in women under adjuvant chemotherapy for breast cancer with the 5-Fluorouracil, Epirubicin and Cyclophosphamide (FEC) regimen","volume":"17","author":"Karamitsos","year":"2013","journal-title":"Hippokratia"},{"issue":"3\u20134","key":"10.1016\/j.jtos.2019.10.008_bib40","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0953-4431(00)00053-9","article-title":"Side effects of chemotherapeutic oculo-toxic agents: a review","volume":"12","author":"Maino","year":"2000","journal-title":"Clin Eye Vis Care"},{"issue":"May","key":"10.1016\/j.jtos.2019.10.008_bib41","first-page":"867","article-title":"Breast cancer medications and Vision\u202f: effects of treatments for early-stage disease","volume":"36","author":"Eisner","year":"2011","journal-title":"Inf Healthc"}],"container-title":["The Ocular Surface"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542012419300527?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542012419300527?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T04:38:06Z","timestamp":1761539886000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542012419300527"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S1542012419300527"],"URL":"https:\/\/doi.org\/10.1016\/j.jtos.2019.10.008","relation":{},"ISSN":["1542-0124"],"issn-type":[{"value":"1542-0124","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dry eye signs and symptoms in aromatase inhibitor treatment and the relationship with pain","name":"articletitle","label":"Article Title"},{"value":"The Ocular Surface","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtos.2019.10.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}